SurModics Acquires BioFX Laboratories

SurModics, Inc., a leading provider of surface modification and drug delivery technologies to the healthcare industry, announced that it has acquired BioFX Laboratories, Inc., a provider of substrates to the in vitro diagnostics industry, for $11.3 million in cash at closing and up to an additional $11.4 million in cash upon the successful achievement of specified revenue targets.
Businesswire